Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

226 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Emerging techniques and technologies in brain tumor imaging.
Ellingson BM, Bendszus M, Sorensen AG, Pope WB. Ellingson BM, et al. Among authors: sorensen ag. Neuro Oncol. 2014 Oct;16 Suppl 7(Suppl 7):vii12-23. doi: 10.1093/neuonc/nou221. Neuro Oncol. 2014. PMID: 25313234 Free PMC article.
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.
Gilbert MR, Pugh SL, Aldape K, Sorensen AG, Mikkelsen T, Penas-Prado M, Bokstein F, Kwok Y, Lee RJ, Mehta M. Gilbert MR, et al. Among authors: sorensen ag. J Neurooncol. 2017 Jan;131(1):193-199. doi: 10.1007/s11060-016-2288-5. Epub 2016 Oct 21. J Neurooncol. 2017. PMID: 27770279 Free PMC article. Clinical Trial.
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.
Schmainda KM, Zhang Z, Prah M, Snyder BS, Gilbert MR, Sorensen AG, Barboriak DP, Boxerman JL. Schmainda KM, et al. Among authors: sorensen ag. Neuro Oncol. 2015 Aug;17(8):1148-56. doi: 10.1093/neuonc/nou364. Epub 2015 Feb 2. Neuro Oncol. 2015. PMID: 25646027 Free PMC article. Clinical Trial.
Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study.
Boxerman JL, Zhang Z, Safriel Y, Larvie M, Snyder BS, Jain R, Chi TL, Sorensen AG, Gilbert MR, Barboriak DP. Boxerman JL, et al. Among authors: sorensen ag. Neuro Oncol. 2013 Jul;15(7):945-54. doi: 10.1093/neuonc/not049. Epub 2013 Jun 19. Neuro Oncol. 2013. PMID: 23788270 Free PMC article. Clinical Trial.
Magnetic resonance imaging of cerebral infarction.
Barest GD, Sorensen AG, Gonzalez RG. Barest GD, et al. Among authors: sorensen ag. Top Magn Reson Imaging. 1998 Aug;9(4):199-207. Top Magn Reson Imaging. 1998. PMID: 9716186
Diffusion magnetic resonance imaging of acute ischemic stroke.
Schaefer PW, Romero JM, Grant PE, Wu O, Sorensen AG, Koroshetz W, González RG. Schaefer PW, et al. Among authors: sorensen ag. Semin Roentgenol. 2002 Jul;37(3):219-29. doi: 10.1016/s0037-198x(02)80022-0. Semin Roentgenol. 2002. PMID: 12226901 Review. No abstract available.
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.
Gerstner ER, Zhang Z, Fink JR, Muzi M, Hanna L, Greco E, Prah M, Schmainda KM, Mintz A, Kostakoglu L, Eikman EA, Ellingson BM, Ratai EM, Sorensen AG, Barboriak DP, Mankoff DA; ACRIN 6684 Trial Group. Gerstner ER, et al. Among authors: sorensen ag. Clin Cancer Res. 2016 Oct 15;22(20):5079-5086. doi: 10.1158/1078-0432.CCR-15-2529. Epub 2016 May 16. Clin Cancer Res. 2016. PMID: 27185374 Free PMC article.
Advances in imaging 2006.
Heiss WD, Sorensen AG. Heiss WD, et al. Among authors: sorensen ag. Stroke. 2007 Feb;38(2):238-40. doi: 10.1161/01.STR.0000254934.95188.a7. Epub 2007 Jan 4. Stroke. 2007. PMID: 17204673 Review. No abstract available.
226 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page